| Product Code: ETC12572725 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Latvia`s lopinavir import shipments continued to show steady growth with a CAGR of 8.6% from 2020 to 2024. The top exporting countries to Latvia for lopinavir include Lithuania, Netherlands, Switzerland, Poland, and Germany. Despite the increasing growth rate of 7.03% from 2023 to 2024, the Herfindahl-Hirschman Index (HHI) indicates low concentration in the market, reflecting a diverse and competitive landscape for lopinavir imports in Latvia. This suggests a healthy market environment with opportunities for various suppliers to participate in meeting the demand for lopinavir in the country.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Lopinavir Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Lopinavir Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Lopinavir Market - Industry Life Cycle |
3.4 Latvia Lopinavir Market - Porter's Five Forces |
3.5 Latvia Lopinavir Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Latvia Lopinavir Market Revenues & Volume Share, By Dosage, 2021 & 2031F |
3.7 Latvia Lopinavir Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Latvia Lopinavir Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 Latvia Lopinavir Market Revenues & Volume Share, By End user, 2021 & 2031F |
4 Latvia Lopinavir Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of HIV/AIDS in Latvia |
4.2.2 Growing awareness about the benefits of lopinavir in HIV treatment |
4.2.3 Government initiatives to improve access to HIV medications |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval and distribution |
4.3.2 Limited healthcare infrastructure and resources in certain regions of Latvia |
5 Latvia Lopinavir Market Trends |
6 Latvia Lopinavir Market, By Types |
6.1 Latvia Lopinavir Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Latvia Lopinavir Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Latvia Lopinavir Market Revenues & Volume, By Antiretroviral, 2021 - 2031F |
6.1.4 Latvia Lopinavir Market Revenues & Volume, By Protease Inhibitor (Anti-HIV), 2021 - 2031F |
6.2 Latvia Lopinavir Market, By Dosage |
6.2.1 Overview and Analysis |
6.2.2 Latvia Lopinavir Market Revenues & Volume, By Tablet, 2021 - 2031F |
6.2.3 Latvia Lopinavir Market Revenues & Volume, By Capsule, 2021 - 2031F |
6.2.4 Latvia Lopinavir Market Revenues & Volume, By Oral solution, 2021 - 2031F |
6.3 Latvia Lopinavir Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Latvia Lopinavir Market Revenues & Volume, By Oral, 2021 - 2031F |
6.3.3 Latvia Lopinavir Market Revenues & Volume, By Other, 2021 - 2031F |
6.4 Latvia Lopinavir Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Latvia Lopinavir Market Revenues & Volume, By Human Immunodeficiency Virus-1 (HIV-1), 2021 - 2031F |
6.4.3 Latvia Lopinavir Market Revenues & Volume, By Others, 2021 - 2031F |
6.5 Latvia Lopinavir Market, By End user |
6.5.1 Overview and Analysis |
6.5.2 Latvia Lopinavir Market Revenues & Volume, By Clinic, 2021 - 2031F |
6.5.3 Latvia Lopinavir Market Revenues & Volume, By Hospital, 2021 - 2031F |
6.5.4 Latvia Lopinavir Market Revenues & Volume, By Others, 2021 - 2031F |
7 Latvia Lopinavir Market Import-Export Trade Statistics |
7.1 Latvia Lopinavir Market Export to Major Countries |
7.2 Latvia Lopinavir Market Imports from Major Countries |
8 Latvia Lopinavir Market Key Performance Indicators |
8.1 Number of healthcare facilities offering lopinavir treatment |
8.2 Patient adherence rate to lopinavir therapy |
8.3 Rate of HIV/AIDS diagnosis and treatment coverage in Latvia |
9 Latvia Lopinavir Market - Opportunity Assessment |
9.1 Latvia Lopinavir Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Latvia Lopinavir Market Opportunity Assessment, By Dosage, 2021 & 2031F |
9.3 Latvia Lopinavir Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Latvia Lopinavir Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 Latvia Lopinavir Market Opportunity Assessment, By End user, 2021 & 2031F |
10 Latvia Lopinavir Market - Competitive Landscape |
10.1 Latvia Lopinavir Market Revenue Share, By Companies, 2024 |
10.2 Latvia Lopinavir Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here